This announcement is a separate document:
国泰君安证券股份有限公司关于国邦医药集团股份有限公司首次公开发行股票并上市2022年度持续督导报告书
Guotai Junan Securities Co., Ltd.'s 2022 Continued Supervision Report on the Initial Public Offering and Listing of Guobang Pharmaceutical Group Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.